Skip to content
  • 6,799 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Solicitation

Notice of Intent Cell Genix for supply of reagents

24-008191

National Institutes of Health, National Institutes of Health - CC. Analytical Laboratory Instrument Manufacturing.

Response deadline

May 16, 2024 at 6:30 AM EDT

Closed 899 days ago. Posted May 2, 2024. Scheduled to archive May 31, 2024.

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one closed in 2024

39 like it are open now in analytical laboratory instrument manufacturing

All 39 open in analytical laboratory instrument manufacturing

Description

As published on SAM.gov.

Notice of Intent Cell Genix for supply of reagents.

Product Service Code: 6550- In Vitro Diagnostic Substances, Reagents, Test Kits and Sets NAICS Code: 334516 - In Vitro Diagnostic Substance Manufacturing (Small Business Size Standards- 1,250 Average Number of Employees)

Place of Performance:

Bethesda, MD 20892 USA POTS:

24-008191 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested. The National Institutes of Health (NIH), Office of Purchasing and Contracts (OPC) intends to award a firm-fixed price to Sartorius Stedim North America Inc, Coralville, Bohemia, NY 11716 on a sole source basis for Sartorius / Cell Genix for the supply of reagents.

The Center for Cellular Engineering (CCE) is responsible for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy and gene therapy conducted in the Clinical Center at the NIH. Cell processing procedures are tailored to each of the 30 or more different patient-care clinical research protocols supported.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.

Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the Office of Purchasing and Contracts, prior to the c650losing date specified in this announcement, electronically to the attention of Damien Goines, Contract Specialist, damien.goines@nih.gov by MAY 16TH, 2024, 6:30AM EST.

Please send your capability statements ONLY. This IS NOT a request for proposal.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 2, 2024

    Solicitation

    Due May 16, 2024 at 6:30 AM EDT. SAM.gov, notice 9e72210a4d624578966e5cc8f5da8d06

Points of contact